ArticleFrontiers in public health2025
Stakeholder perspectives and the challenges in implementing hepatitis C elimination policy in Pakistan.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model.Tropical medicine and infectious disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite significant achievements in combating hepatitis C (HCV), HCV remains a major global public health issue with approximately 71 million cases and 400,000 deaths annually. The international community has taken several important steps for HCV control, including the Global Health Sector Strategy (2016-2021), the Global Hepatitis Action Plan (2011), and the United Nations Sustainable Development Goals (UN-SDGs) for 2030. However, achieving the World Health Assembly's goal of eliminating HCV by 2030 treating 90% of all infected individuals remains a significant challenge, particularly in Pakistan. This study delves into the perspectives of key stakeholders involved in the hepatitis elimination policy and its implementation in Pakistan, identifying barriers to effective policy execution and highlighting motivating factors. Through a phenomenological approach, interviews were conducted with ten key informants, including policymakers, clinicians and provincial hepatitis program personnel. Thematic analysis uncovered several critical themes: perceptions of hepatitis and elimination policies, the feasibility of achieving elimination goals, international collaborations, policy development, gaps in epidemiological data, and the influence of political contexts. The findings emphasize the need for a robust national database, stronger political commitment, better resource allocation, and a more integrated healthcare system. Drawing on successful models, such as Egypt, the study suggests that Pakistan must adopt comprehensive and coordinated strategies to meet the WHO targets and eliminate hepatitis by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.